| Dr Kunal Patel, MD | |
|
1250 S Cedar Crest Blvd Ste 300, Allentown, PA 18103-6381 | |
| (610) 402-3110 | |
| (610) 402-3112 |
| Full Name | Dr Kunal Patel |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 15 Years |
| Location | 1250 S Cedar Crest Blvd Ste 300, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346484664 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lehigh Valley Hospital | Allentown, PA | Hospital |
| Lehigh Valley Hospital - Hazleton | Hazleton, PA | Hospital |
| St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lehigh Valley Physician Group | 3072425123 | 1763 |
News Archive
This paper criticizes the methodology of a meta-analysis and 8 studies published in the JAMA last year which indicated that longer term psychodynamic psychotherapy (LTPP) was more effective than short therapies. The investigators found a miscalculation of the effect sizes used to make key comparisons and found no evidence to support claims of superiority of LTPP over shorter-term methods of psychotherapy.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the second quarter ended June 30, 2010. The Company's partner, Auxilium Pharmaceuticals, Inc. markets XIAFLEX (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, for the treatment of adult Dupuytren's contracture patients with a palpable cord.
The American Institute of Ultrasound in Medicine (AIUM) will host an Ultrasound First Forum on November 12, 2012, in New York, New York. The forum will address the expanding role of ultrasound imaging as a "first" imaging examination and will be devoted to encouraging the use of ultrasound as a safe, effective, and affordable alternative to other diagnostic imaging modalities where scientific evidence supports its appropriateness.
University of Granada researchers have developed a software tool that makes an accurate estimation of the risk that a person has to suffer a heart disease. In addition, this software tool allows the performance of massive risk estimations, i.e. it helps estimating the risk that a specific population group has of suffering a heart condition. The researchers employed a sample including 3 000 patients.
› Verified 5 days ago
| Entity Name | Lehigh Valley Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
This paper criticizes the methodology of a meta-analysis and 8 studies published in the JAMA last year which indicated that longer term psychodynamic psychotherapy (LTPP) was more effective than short therapies. The investigators found a miscalculation of the effect sizes used to make key comparisons and found no evidence to support claims of superiority of LTPP over shorter-term methods of psychotherapy.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the second quarter ended June 30, 2010. The Company's partner, Auxilium Pharmaceuticals, Inc. markets XIAFLEX (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, for the treatment of adult Dupuytren's contracture patients with a palpable cord.
The American Institute of Ultrasound in Medicine (AIUM) will host an Ultrasound First Forum on November 12, 2012, in New York, New York. The forum will address the expanding role of ultrasound imaging as a "first" imaging examination and will be devoted to encouraging the use of ultrasound as a safe, effective, and affordable alternative to other diagnostic imaging modalities where scientific evidence supports its appropriateness.
University of Granada researchers have developed a software tool that makes an accurate estimation of the risk that a person has to suffer a heart disease. In addition, this software tool allows the performance of massive risk estimations, i.e. it helps estimating the risk that a specific population group has of suffering a heart condition. The researchers employed a sample including 3 000 patients.
› Verified 5 days ago
| Entity Name | Schuylkill Health System Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588603567 PECOS PAC ID: 0840285532 Enrollment ID: O20040420001197 |
News Archive
This paper criticizes the methodology of a meta-analysis and 8 studies published in the JAMA last year which indicated that longer term psychodynamic psychotherapy (LTPP) was more effective than short therapies. The investigators found a miscalculation of the effect sizes used to make key comparisons and found no evidence to support claims of superiority of LTPP over shorter-term methods of psychotherapy.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the second quarter ended June 30, 2010. The Company's partner, Auxilium Pharmaceuticals, Inc. markets XIAFLEX (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, for the treatment of adult Dupuytren's contracture patients with a palpable cord.
The American Institute of Ultrasound in Medicine (AIUM) will host an Ultrasound First Forum on November 12, 2012, in New York, New York. The forum will address the expanding role of ultrasound imaging as a "first" imaging examination and will be devoted to encouraging the use of ultrasound as a safe, effective, and affordable alternative to other diagnostic imaging modalities where scientific evidence supports its appropriateness.
University of Granada researchers have developed a software tool that makes an accurate estimation of the risk that a person has to suffer a heart disease. In addition, this software tool allows the performance of massive risk estimations, i.e. it helps estimating the risk that a specific population group has of suffering a heart condition. The researchers employed a sample including 3 000 patients.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kunal Patel, MD Po Box 783311, Philadelphia, PA 19178-3311 Ph: (484) 884-4500 | Dr Kunal Patel, MD 1250 S Cedar Crest Blvd Ste 300, Allentown, PA 18103-6381 Ph: (610) 402-3110 |
News Archive
This paper criticizes the methodology of a meta-analysis and 8 studies published in the JAMA last year which indicated that longer term psychodynamic psychotherapy (LTPP) was more effective than short therapies. The investigators found a miscalculation of the effect sizes used to make key comparisons and found no evidence to support claims of superiority of LTPP over shorter-term methods of psychotherapy.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the second quarter ended June 30, 2010. The Company's partner, Auxilium Pharmaceuticals, Inc. markets XIAFLEX (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, for the treatment of adult Dupuytren's contracture patients with a palpable cord.
The American Institute of Ultrasound in Medicine (AIUM) will host an Ultrasound First Forum on November 12, 2012, in New York, New York. The forum will address the expanding role of ultrasound imaging as a "first" imaging examination and will be devoted to encouraging the use of ultrasound as a safe, effective, and affordable alternative to other diagnostic imaging modalities where scientific evidence supports its appropriateness.
University of Granada researchers have developed a software tool that makes an accurate estimation of the risk that a person has to suffer a heart disease. In addition, this software tool allows the performance of massive risk estimations, i.e. it helps estimating the risk that a specific population group has of suffering a heart condition. The researchers employed a sample including 3 000 patients.
› Verified 5 days ago
Jessica Mary Boehmler, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 205, Allentown, PA 18103 Phone: 610-439-8856 Fax: 610-439-8856 | |
Muhammad Majeed, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-5369 | |
Allison Jane Baragona, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1501 N Cedar Crest Blvd Ste 110, Allentown, PA 18104 Phone: 610-821-2828 Fax: 610-821-7915 | |
James A Burke, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 300, Allentown, PA 18103 Phone: 610-402-3110 Fax: 610-402-3112 | |
Stephen R Shore, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1901 Hamilton St Ste 300, Allentown, PA 18104 Phone: 610-628-7900 Fax: 833-816-7513 | |
Tarika Sejal Chowdhary, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 17th & Chew, Suite 101, Allentown, PA 18105 Phone: 610-969-4370 | |
Ashley Vojtek, DO Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 484-862-3200 |